Drug companies furiously fight new FDA safety labeling guidelines

Friday, March 21, 2014 by: J. D. Heyes
Tags: drug companies, safety labeling, FDA guidelines

eTrust Pro Certified

Most Viewed Articles
Popular on Facebook
BACK INTO THE CLOSET: Why U.S. reporters are not allowed to write about rainbow events in nations where being gay is still condemned
Depopulation test run? 75% of children who received vaccines in Mexican town now dead or hospitalized
A family destroyed: Six-month-old dies after clinic injects baby with 13 vaccines at once without mother's informed consent
Biologist explains how marijuana causes tumor cells to commit suicide
INVESTIGATION: Three days before Dr. Bradstreet was found dead in a river, U.S. govt. agents raided his research facility to seize a breakthrough cancer treatment called GcMAF
BOMBSHELL: China and America already at war: Tianjin explosion carried out by Pentagon space weapon in retaliation for Yuan currency devaluation... Military helicopters now patrolling Beijing
Companies begin planting microchips under employees' skin
BAM! Chipotle goes 100% non-GMO; flatly rejecting the biotech industry and its toxic food ingredients
ECONOMIC SLAVERY FOR ALL: While we were distracted with the Confederate flag flap, Congress quietly forfeited our entire economic future via fast-track trade authority
NJ cops bust teenagers shoveling snow without a permit
McDonald's in global profit free fall as people everywhere increasingly reject chemically-altered toxic fast food
March Against Monsanto explodes globally... World citizens stage massive protests across 38 countries, 428 cities... mainstream media pretends it never happened
Italian court rules mercury and aluminum in vaccines cause autism: US media continues total blackout of medical truth
SCOTUS same-sex marriage decision may have just legalized the concealed carry of loaded firearms across all 50 states, nullifying gun laws everywhere
Orthorexia Nervosa - New mental disorder aimed at people who insist on eating a clean diet
Vicious attack on Dr. Oz actually waged by biotech mafia; plot to destroy Oz launched after episode on glyphosate toxicity went viral
Nearly every mass shooting in the last 20 years shares one surprising thing? and it's not guns
Holistic cancer treatment pioneer Dr. Nicholas Gonzalez dies suddenly; patients mourn the loss of a compassionate, innovative doctor who helped thousands heal from cancer
(NaturalNews) The makers of generic drugs are vigorously opposing a new proposed rule by the Food and Drug Administration which would mandate that they change prescribing information on their products if they obtain new safety information, a change they claim would subject them to product liability lawsuits.

According to Reuters, the rule -- if finally approved and implemented -- would overturn other regulations in place for the past 30 years that ban generic medication manufacturers from updating safety messages on labels if similar changes have not been made by the company that originally developed the drug:

The Food and Drug Administration, which issued its proposal in November, said the change is designed to "create parity" between branded and generic drug makers with respect to labeling changes, and remove an unnecessary impediment to the prompt communication of safety data.

Generic drugmakers say the proposed rule would raise the cost of drugs and lead to confusion among consumers.

'We cannot support a rule that undermines public health'

"Disregarding decades of regulatory stability in this way will create unwarranted confusion, raises patient safety concerns and threatens the system that created thousands of affordable options for consumers," Gordon Johnston, a former deputy director of the FDA's generic drugs division and currently an industry consultant, said in a statement.

Equally important, say some, is that the change could make generic drugmakers even more vulnerable to product liability suits than they currently are.

"The Generic Pharmaceutical Association cannot support a proposed rule that undermines public health merely to facilitate litigation against generic drug companies by the plaintiffs' bar," the association said in a position paper in February.

A congressional subcommittee, the House Energy and Commerce Committee's health panel, heard testimony regarding the proposed changes during a hearing on March 3.

In 1984, lawmakers passed, and President Ronald Reagan signed, the Hatch-Waxman Act, in an effort to speed up the approval of generic drugs, which are much cheaper than name brands. Since then, the industry has exploded; today, Reuters reports, generic drugs make up 80 percent of all prescriptions filled in the U.S.

And since generic drugs are made to essentially act the same as brand-name drugs, the FDA has historically forbidden generic manufacturers from making changes to their product labels independent of the drug developer.

That changed a couple of years ago. More from Reuters:

In 2011, after years of legal wrangling, the Supreme Court ruled that the FDA's prohibition on label changes meant generic drugmakers should not be held accountable for a failure to warn against risk. As a result, consumers taking a brand name drug can have legal recourse if they are injured by a drug, but those taking a generic effectively do not.

The FDA's proposal would remove that protection and place equal responsibility for monitoring drug safety on the brand company and the generic manufacturers.

If you are a fan of labeling, this proposed rule change, then, should be welcomed.

'Brand-name makers have less incentive to monitor safety post-approval'

In fact, according to supporters, the proposed rule is necessary because there are about 2,000 generic drugs on the market -- about 45 percent of all generics sold -- for which no branded counterpart is currently being produced.

"If generic manufacturers are not actively monitoring and proposing safety updates, no manufacturer is doing so at all," said Allison Zieve, general counsel at consumer watchdog Public Citizen, in testimony to be delivered to the House panel. "As generic market share increases, the brand-name manufacturer loses incentive to devote resources to post-approval safety monitoring."

Her organization filed a petition in 2011 asking the FDA to allow generic drug manufacturers to change their product labeling via procedures that are currently available to brand-name makers.

"This proposal will help ensure that health care professionals and consumers have access to the latest safety information for the medications they use," said Janet Woodcock, M.D., director of the FDA's Center for Drug Evaluation and Research, in a press release. "More than 80 percent of prescriptions filled in the U.S. are for generics, so we want to make sure that generic drug companies actively participate with the FDA to ensure that product safety information is accurate and up to date."





Follow real-time breaking news headlines on
Drug companies at FETCH.news
Join over four million monthly readers. Your privacy is protected. Unsubscribe at any time.
comments powered by Disqus
Take Action: Support NaturalNews.com by linking back to this article from your website

Permalink to this article:

Embed article link: (copy HTML code below):

Reprinting this article:
Non-commercial use OK, cite NaturalNews.com with clickable link.

Follow Natural News on Facebook, Twitter, Google Plus, and Pinterest

Colloidal Silver

Advertise with NaturalNews...

Support NaturalNews Sponsors:

Advertise with NaturalNews...


Sign up for the FREE Natural News Email Newsletter

Receive breaking news on GMOs, vaccines, fluoride, radiation protection, natural cures, food safety alerts and interviews with the world's top experts on natural health and more.

Join over 7 million monthly readers of NaturalNews.com, the internet's No. 1 natural health news site. (Source: Alexa.com)

Your email address *

Please enter the code you see above*

No Thanks

Already have it and love it!

Natural News supports and helps fund these organizations:

* Required. Once you click submit, we will send you an email asking you to confirm your free registration. Your privacy is assured and your information is kept confidential. You may unsubscribe at anytime.